Nov 05, 2019
Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Aug 28, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences
Jul 25, 2019
Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019
Jul 02, 2019
Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors
May 28, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences
May 02, 2019
Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Apr 30, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences
Apr 25, 2019
Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019
Mar 28, 2019
Viking Therapeutics to Participate in Upcoming Investor Conferences
Mar 13, 2019
Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Jan 02, 2019
Viking Therapeutics to Present at Biotech Showcase 2019
Nov 07, 2018
Viking Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
Oct 31, 2018
Viking Therapeutics to Report Financial Results for Third Quarter 2018 on November 7, 2018
Oct 04, 2018
Viking Therapeutics Announces VK2809 Phase 2 Study Results Selected for Oral Late-Breaker Presentation at The Liver Meeting® 2018
Oct 01, 2018
Viking Therapeutics Presents Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture in Plenary Oral Presentation at ASBMR 2018 Annual Meeting
Sep 26, 2018
Viking Therapeutics to Participate in Upcoming Investor Conferences
Sep 19, 2018
Viking Therapeutics Announces Proposed Public Offering of Common Stock
Aug 28, 2018
Viking Therapeutics to Participate in Upcoming Investor Conferences
Aug 09, 2018
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 02, 2018
Viking Therapeutics to Report Financial Results for Second Quarter 2018 on August 9, 2018